Anagram
PrivateLast Round
Series A
Feb 26, 2025
Total Funding Raised
$25.38M
Company Overview
Anagram is a financial software company that provides a unified revenue cycle management SaaS platform that automates vision insurance billing and claims management for eye care providers.
Sector
Healthcare & Life Sciences
Verticals
Vertical SaaS, Revenue Cycle, InsurTech
Business Model
B2B
Customer Profile
Subscription SaaS, Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Anagram Comps
Public and private peers based on sector, stage, and business model.
Anagram Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 26, 2025 | ||||
| Series A | Feb 26, 2020 | ||||
| Seed | Aug 15, 2019 |
Anagram Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Launchpad Digital Health | Seed, Series A |
| General Catalyst | Series A |
| Madrona Venture Group | Series A |
| ManchesterStory Group | Series A |
| Secure Octane | Series A |
| Rogue Venture Partners | Seed, Series A |
| Bloomberg Beta | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 13, 2026
Processes hundreds of millions of dollars in eye care billing annually.
- Mar 13, 2026
Over 2,000 eye care professionals now use the platform.
Anagram Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Anagram's valuation, stock price, and market status.